Aerovate Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $14M | 627k | 22.63 |
| 2023-09-30 | $8.1M | 599k | 13.57 |
| 2023-06-30 | $9.0M | 524k | 17.15 |
| 2023-03-31 | $10M | 513k | 20.17 |
| 2022-12-31 | $15M | 500k | 29.30 |
| 2022-06-30 | $6.9M | 442k | 15.63 |
| 2022-03-31 | $8.8M | 480k | 18.33 |
| 2021-09-30 | $16M | 781k | 20.98 |